LDS/Medical Tests/Renin Activity

Renin Activity

Renin is an enzyme that plays a role in maintaining salt and fluid levels in our body. Renin is produced by the juxtaglomerular apparatus cells in the kidney cortex in response to decreased blood pressure as measured at the renal glomerulus and/or decreased salt concentration as measured at the macula densa at the distal renal tubule, and/or decreased fluid levels in our body. The thirst mechanism is also a very important factor in fluid retention; however, sick patients may not have access to fluids or may not be able to retain ingested fluids. Renin performs its function by converting angiotensinogen to angiotensin I, which is then converted to angiotensin II by angiotensin converting enzyme (ACE), which is believed to be released mostly from lung and kidney capillaries; ACE removes two amino acids from the angiotensin I chain, thereby converting a decapedtide into an octapeptide. Angiotensin II is a potent vasopressor and acts as a constrictor of blood vessels resulting in increased blood pressure. Angiotensin II also stimulates the adrenal cortex to produce the hormone aldosterone, which promotes the retention of sodium in the distal tubule, thereby increasing water retention by the osmotic effect. Renin activity is measured by the ability of the patient's plasma renin to generate angiotensin I from plasma angiotensinogen.  The result is measured as ng of angiotensin I produced per mL of plasma per hour.  Plasma renin activity is usually used with the plasma aldosterone to screen for aldosteronism and it is part of the renin-angiotensin system or RAS. The ratio of plasma aldosterone concentration to plasma renin activity is an effective screening test for primary aldosteronism with a sensitivity >95%. It has a high negative predictive value even during antihypertensive therapy. Because of a low specificity of the ratio, aldosterone production must be confirmed by the aldosterone suppression test. Renin activity is increased in hyperaldosteronism, chronic renal failure, nephrotic syndrome, congestive heart failure with left ventricular hypertrophy, adrenal insufficiency and water loss or dehydration. Decreased levels are seen in hypoaldosteronism and with some drugs that regulate the RAS such as diuretics and beta blockers.

  • Diagnosis of primary or secondary aldosteronism
  • Aids in assessing mineralocorticoid therapy and patient compliance
  • Evaluation of severe hypertension
  • Evaluation of edematous normotensive conditions
  • Evaluation of hypokalemic normotensive states
  • Work up of adrenocortical disorders
  • As an aid in diagnosis of nephrotic syndrome
  • As an aid in diagnosis of heart failure

Increased in:

  • Dehydration
  • Some hypertensive states such as renal artery stenosis
  • Unilateral renal disease
  • Some edematous normotensive states such as in cirrhosis, nephrotic syndrome and congestive heart failure
  • Gastrointestinal disorders with sodium and potassium loss
  • Adrenocortical insufficiency
  • Renal diseases with Na^
  • or K^
  • loss
  • Left ventricular hypertrophy
  • Renin-secreting tumors
  • Oral contraceptive induced hypertension
  • Juxtaglomerular cell hyperplasia (Bartter's syndrome)

Decreased in:

  • Hyporeninemic hypoaldosteronism
  • Adrenal adenoma-producing primary aldosteronism
  • Some hypertensive states such as primary aldosteronism and preeclampsia
  • Some drugs such as beta blockers, diuretics, aspirin, methyldopa, indomethicin
Group / Condition ng AI/mL/hr or mg AI/hr/L
Cord blood 4.0–32.0
Newborn (1–7 days) 2.0–35.0
Child – Normal Sodium Diet (Supine)
1–12 months 2.4–37.0
1–3 years 1.7–11.2
3–5 years 1.0–6.5
5–10 years 0.5–5.9
10–15 years 0.5–3.3
Adult – Normal Sodium Diet
Supine 0.2–1.6
Standing (4 hr) 0.7–3.3

Radioimmunoassay, chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).

.

Plasma EDTA (Lavender).

Immediately centrifuge using a refrigerated centrifuge and aliquot plasma into a plastic vial and freeze.

Stability

  • Ambient: unstable
  • Refrigerated: unstable
  • Frozen: 28 days
Aldosterone, Electrolyte panel, Angiotensin Converting Enzyme, Captopril suppression test, Renin stimulation testing.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Curr Cardiol Rep. 2005;7:412. [PMID: 16256009]
  • Clin Endocrinol (Oxf). 2007 May;66(5):607-18. [PMID: 17492946]
  • Methods Mol Biol. 2006;324:187. [PMID: 16761379]
  • Nat Clin Pract Nephrol. 2006;2:198. [PMID: 16932426]
  • Bishop ML, Duben-Engelkirk JL, Fody EP. Clinical Chemistry Principles, Procedures, Correlations. Philadelphia. Lippincott (1996)
  • Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757